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Available online 16 May 2011Abstract We have generated a human feeder cell line from early second trimester Placental Stromal Fibroblasts (ihPSF) stably
over-expressing the polycomb protein BMI-1. These feeder cells retain the ability to maintain human Embryonic Stem cells
(hESc) over long-term culture whereas hTERT or BMI-1/hTERT immortalised feeder cell lines do not. ihPSFs were able to support
the derivation of a new hESc line in near xenofree (free of non-human animal components) conditions and support continued
culture of newly derived hESc and human induced Pluripotent Stem (hiPS) cell lines in complete xenofree conditions necessary
for clinical use.
© 2011 Elsevier B.V. All rights reserved.Introduction
The potentially inexhaustible supply of self-renewing plu-
ripotent human embryonic stem (hES) cells holds promise as
a target source of transplantation material for the treatment
of a myriad of debilitating and degenerative diseases. To⁎ Corresponding author at: Department of Endocrinology, William
Harvey Research Institute, Queen Mary University of London EC1M
6BQ, UK.
E-mail address: t.mckay@qmul.ac.uk (T.R. McKay).
1873-5061/$ - see front matter © 2011 Elsevier B.V. All rights reserved
doi:10.1016/j.scr.2011.04.005date, the vast majority of hES cell lines have been derived on
Mouse Embryonic Feeder (MEF) cells but these lines are
inappropriate for clinical use because of the necessity for
xenofree processing. There have been numerous reports
describing the maintenance of hES colonies on primary
human feeder layers from adult, neonatal and foetal sources
including term and pre-term placenta (Deleu et al., 2009; Ilic
et al., 2008; Liu et al., 2010; Tecirlioglu et al., 2010).
Alternatives to primary cells include autogeneic cultures of
human feeders derived from hES cells (Choo et al., 2008; Li
et al., 2011), feeder-free (Hernandez et al., 2010; Rodin et
al., 2010; Thomas et al., 2009), feeder-conditioned.
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suspension culture (Larijani et al., 2011). Although clinical
grade, xenofree hES cell lines have recently been success-
fully derived on primary human feeders (Unger et al., 2008)
such feeders are subject to donor supply and variability.
A repeatable and scalable process of hES cell derivation
and scale-up would require a xenofree, clinical grade feeder
cell line. Choo et al. generated a hES feeder cell line using
HPV E6/E7 immortalization but this line has not become
widely used (Choo et al., 2006). More recently Unger et al.
used a combination of BMI-1 and hTERT to generate a feeder
cell line (Unger et al., 2009). The use of BMI-1 as an anti-
senescing factor and hTERT as an immortalization factor has
been reported for a number of cell types (Fulcher et al.,
2009; Haga et al., 2007). However, hTERT immortalization
has been shown to elicit a premalignant phenotype which
could be deleterious in a feeder cell context (Milyavsky et
al., 2003). We directly compared different modes of cell
immortalization and found that BMI-1 over-expression alone
resulted in a feeder cell line most able to maintain ES cell
phenotype over multiple passages.
Results and discussion
Purified hPSF support hESc growth and maintenance
Mouse embryonic cells have been proven more capable of
maintaining ESc colonies than adult mouse cells. To obtain a
human equivalent to facilitate the xenofree culture and
derivation of hESc we isolated and purified human Placental
Stromal Fibroblasts (hPSF) from the conceptus derived
chorionic villi of donated first and early second trimester
placentas (a total of 6 placentae were obtained between 10
and 15 weeks post-conception). Purified primary hPSFs were
cultured on human gelatin-coated plates for 3 passages (P3)
then analysed using lineage specific markers. The prolifer-
ative adherent fraction persisting at P6 was confirmed to
have a fibroblastic phenotype by immunohistochemistry
(FSP+, CD45−/CD31−/K18−) (Fig. 1a). hPSF cultures were
grown to P6 then mitotically inactivated alongside P3 MEF
cultures and assessed for their ability to maintain pluripotent
colonies of the hESc lines HUES7 (P42) and HES3 (P45). These
were grown and maintained for at least 6 passages on both
feeder cell types (Fig. 1b). There was no observable
difference in HUES7 growth rates on either hPSFs or MEFs
as defined by average colony area measured during real-time
imaging (data not shown). Cells grown on hPSFs retained
pluripotency to a comparable degree to those grown on MEFs
as assessed by Nanog, OCT4, Tra-1-60 and Tra1-81 immu-
nostaining (Fig. 1c) and were able to differentiate to cell-
types representing all three germ lineages after Embryoid
Body (EB) formation and re-plating (Supplementary Fig.1).
Generation of an ihPSF cell line
To introduce continuity into hESc derivation and continued
culture we sought to create a human feeder cell line from
hPSFs. We investigated a combination strategy of transgeni-
cally over-expressing the polycomb protein BMI-1 and the
catalytic domain of human telomerase, hTERT, compared to
individual expression (Supplementary Fig. 2). hPSF cultureswere transduced at low multiplicity of infection (MOI~10)
and selected by antibiotic resistance (Retro-hTERTiresPuro)
or GFP expression (Lenti-BMI-1iresGFP). However, it became
apparent that over serial passages BMI-1/GFP expressing
cells were selectively enriched, increasing from an initial
transduction efficiency of 67±7% GFP positive hPSFs to
maintenance of a ~94±2% GFP positive population for over
12 months (n=6± s.e.m.) (Supplementary Fig. 3). This
enrichment was not observed for GFP expressing cells
suggesting that BMI-1 expression provides a growth or
selection advantage.
Our new cell lines were analysed for transgene expression
and functional activity at low passage (P6) and extended
passage (P25). BMI-1 intrinsically inhibits cellular senescence
by repressing p16(INK4a)-mediated cell senescence and is
transcriptionally upregulated by the mitogen C-MYC (Guney
et al., 2006). hTERT maintains chromosomal telomere length
and extrinsically promotes cell cycle progression by inhibit-
ing p21. However, recent reports show hTERT transcription-
ally upregulates C-MYC which itself upregulates hTERT in a
positive feedback loop that can ultimately result in apoptosis
(Milyavsky et al., 2003). We observed increased BMI-1
expression at both the mRNA and protein level from P6 to
P25 in BMI-1 and BMI-1/hTERT hPSFs (Fig. 2a and Supple-
mentary Fig. 4a). This is not due to a proliferation advantage
in BMI-1 expressing cells as the percentage of BMI-1/GFP
positive cells peaked at P6 and remained constant to P25. To
confirm functional activity of BMI-1 we assessed repression of
the downstream target p16 by western blot. This revealed
repression of p16 activity in BMI-1 expressing cells at P6 and
P25 but a clear p16 immunoproduct was present in BMI-1/
hTERT cells at P25. hTERT mRNA and protein remained
relatively constant between P6 and P25 (Supplementary Fig.
4a and b) but telomerase activity was markedly reduced in
BMI-1/hTERT cells compared to hTERT alone at P25
(pb0.001; n=6±s.e.m.) (Fig. 2b). Levels of p21 protein,
which hTERT directly inhibits, were barely detectable
throughout the experiment in all samples except those
over-expressing BMI-1 alone (Supplementary Fig. 3b). These
data indicate that after extended passage the hTERT
transduced hPSFs lose telomerase activity in the presence
of BMI-1 and conversely hTERT has a negative effect on BMI-1
inhibition of p16. We hypothesised that this effect could be
caused by increased expression of the mitogen C-MYC leading
to apoptosis in BMI-1/hTERT cells. Indeed, C-MYC mRNA
increased in cells transgenically expressing hTERT over
extended passage (Fig. 2c). We analysed the proliferation
rate of P6 and P25 hPSF cells by cell counting over 14 days
and BrdU incorporation during S-phase. There was no
significant difference between the proliferation rate or
percentage of cells in S-phase in any of our cell lines at P6
(Supplementary Fig. 5a and b). When cell proliferation was
assessed at P25 there were significantly more cells after
14 days in BMI-1 cultures compared to BMI-1/hTERT (Fig. 2d,
pb0.001; n=4±s.e.m.) but no significant difference in the
number of cells entering S-phase (n=4). TUNEL assays on our
transgenic hPSF groups at P25 confirmed that there was a
significant increase of apoptotic nuclei in BMI-1/hTERT cells
compared to BMI-1 and hTERT alone (Fig. 2e pb0.05; n=6±
s.e.m.). Collectively, these data indicate that separately,
BMI-1 and hTERT contribute to perpetuating cellular prolifer-
ation. Combined expression of BMI-1/hTERT over extended
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Figure 1 Primary hPSFs are able to support the growth and maintenance of hESc. Human Stromal Fibroblasts were isolated and
purified from the chorionic villus fraction of first and second trimester placentae. (a) Adherent cells were immunostained for the
presence of the lineage specific markers; fibroblast specific protein (FSP), haematopoietic marker CD45, endothelial marker CD31 and
epithelial marker K18. Images are representative of 3 independent isolation experiments (size bar=20 μm). (b) HUES7 and HES3 hESc
colonies were serially mechanically passaged on mitotically inactivated hPSFs (P6) or MEFs (P3) for at least 4 passages in 3 independent
experiments (size bar=50 μm). (c) Colonies retained pluripotency as evidenced by Nanog, OCT4, Tra1-60 and Tra-1-81 immunostaining
of HUES7 hESc (n≥3, size bar=20 μm). Immunocytochemistry experiments were accompanied with the appropriate isotype antibody
controls that were negative for all markers.
156 T.R. McKay et al.passage results in a loss of p16 inhibition and an increase in
apoptosis that could be due to an increase in C-MYC
expression.Characterisation of ihPSF phenotype
We analysed growth factors (GF) and extra cellular matrix
(ECM) components in an attempt to define the hESc
maintenance factors perpetuated in ihPSFs. We compared
P8 primary hPSFs which are unable to maintain hESc culture
with P25 ihPSFs. A preliminary candidate approach showed
no increase in transcripts for FGF2 or Activin A, GFs
implicated in hESc maintenance (Supplementary Fig. 6a).
However, a Coomassie stained PAGE analysis of ECM extract
showed that in 3 of 4 cell cultures a substantial increase in
protein bands around 250 kDa was evident in ihPSFs
compared to hPSFs (Supplementary Fig. 6b). Subsequent
western analysis showed that this corresponded to fibronec-
tin which is known to be an important component of ECM
capable of maintaining hESc (Fig. 2f i and ii). These data
imply that BMI-1 expression protects the hESc maintenanceintegrity of ihPSFs critically in terms of ECM deposition and
composition.Prolonged maintenance of hESc/hiPSc colonies on
ihPSFs
We first compared the ability of our transgenic hPSF cell lines
to maintain the growth of the HES3 and HUES7 hESc lines and
two hiPSc (iPSA and iPSB) lines. Mitotically inactivated
feeder layers were prepared at P6, 12 and 25 (primary
hPSFs terminally senesced beyond P12) then mechanically
passaged hESc/hiPSc colonies for up to 6 passages on these
feeder cells. Only BMI-1 and BMI-1/hTERT transduced hPSFs
were able to maintain pluripotent hESc/hiPSc colonies at
P12, while colonies began to differentiate (as ascertained by
gross morphology) or die after 3 passages on primary, sham
transduced and hTERT transduced hPSFs. Although both BMI-1
and BMI-1/hTERT transduced hPSFs maintained colonies at
P12, by P25 only BMI-1 transduced hPSFs maintained hESc/
hiPSc growth. hiPSc were maintained as colonies even on P12
hPSFs, unlike hESc, suggesting that hiPSc are more robustly
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Figure 2 BMI-1 expression in hPSFs maintains feeder cell phenotypic integrity. (a) BMI-1 and p16 activity were assayed in transduced
hPSFs at P6 and P25 by western blotting. Blots are representative of two independent experiments. (b) Telomerase activity was
measured using a fluorescence Telomeric Repeat Amplification Protocol (TRAP). Data represent a single experiment where n=3.
(c) C-MYC expression was quantified the cell lines at P6 and P25 using qRT-PCR (n=6±s.e.m.). (d) Cell proliferation was assessed at
P25 by cell counting over 14 days. (e) Apoptotic index was calculated using the TUNEL assay. (f) A comparison of extracellular
fibronectin secreted by hPSFs at P8 (i) and ihPSFs at P25 (ii) by western blot on extracellular matrix; 1×, 3×, 5× indicate relative
protein loading. Unless otherwise stated all experiments were carried out at a minimum of n=4±s.e.m.
157Human feeder cell line for derivation and culture of hESc/hiPScmaintained than hESc (Table 1 and Supplementary Fig. 7).
We isolated and amplified 10 BMI-1 transduced clones by
serial dilution and colony picking in order to establish ahomogeneous cell line (ihPSF). All 10 clones maintained the
growth of HUES7 colonies so a single line was chosen at
random to continue analyses. Three established hESc lines
Table 1 Maintenance of pluripotent HES3, HUES7, iPSA and iPSB colonies on early (P6) andmid- (P12) passage hPSFs. First column
shows gene over expressed. None=pimary starting PSFs. Ticks indicate maintenance of pluripotency after at least 3 serial
passages as evidenced by N90% OCT4 and Nanog positive immunostaining in all colonies analysed. A cross indicates b90% staining,
NA indicates Not Analysed.
Transgene HES3 HUES7 iPSA iPSB
P6 P12 P25 P6 P12 P25 P6 P12 P25 P6 P12 P25
None ✓ x NA ✓ x NA ✓ ✓ NA ✓ ✓ NA
BMI-1 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
BMI-1/hTERT ✓ ✓ x ✓ ✓ x ✓ ✓ ✓ ✓ ✓ ✓
hTERT ✓ x x ✓ x x NA NA NA NA NA NA
GFP ✓ x x ✓ x x NA NA NA NA NA NA
PuromycinR ✓ x x ✓ x x NA NA NA NA NA NA
158 T.R. McKay et al.(HUES1, HUES7 and HES3), two in-house lines (MAN-1 and
MAN-2) and two hiPSc lines (iPSA and iPSB) were successfully
maintained over 4–20 mechanical and/or trypsin-mediated
passages on mitotically inactivated ihPSFs at P6 and P25
(Table 2 and Supplementary Movies 1 and 2). All hESc lines
immunostained positive for the pluripotency markers OCT4
and SSEA3 and were karyotypically stable (data not shown).GMP derivation and xenofree maintenance of hESc
on ihPSFs
To move toward clinical viability, we attempted the
derivation of a new hESc line from a donated blastocyst on
ihPSFs under cGMP conditions. All components used were
xenofree apart from Knockout Serum Replacement due to
the lack of a viable alternative at the time. A line was
successfully derived as outlined in Materials and methods
(Fig. 3a i–iii). To our knowledge this is the first example of a
hESc derivation on a clonal feeder cell line. We maintained
ihPSFs and primary hPSFs in completely xenofree conditions
over multiple passages to assess their long-term viability.
The proliferation rate of primary hPSFs was significantly
reduced after 14 days of xenofree culture compared to
standard conditions (pb0.05; n=6±s.e.m.), whereas there
was no significant difference for ihPSFs (Fig. 3b). Finally,
multiple hESc colonies were cultured on inactivated ihPSFTable 2 Passage of multiple cell lines on ihPSFs mitotically
inactivated at low passage (P6) or extended passage (P25).
M indicates mechanical passage, T indicates trypsin
passage. Colonies were confirmed as being pluripotent by
morphology and OCT4/Nanog staining. Passage given is
maximum at which line tested.
hES cell line hES passage no. hES passage no.
(P6 ihPSF) (P25 ihPSF)
MAN-1 P6 (M) P6 (M)
MAN-2 P4 (M) P6 (T/M)
HUES1 P6 (T/M) P20 (M)
HUES7 P6 (T/M) P6 (M)
HES3 P10 (M) P10 (T), P20 (M)
hiPSA N/A P6 (T/M)
hiPSB N/A P6 (T/M)feeders for at least 4 passages. Colonies had distinct ES cell
morphology and were positive for the pluripotency markers
OCT4, Nanog and SSEA3 by immunohistochemistry (Fig. 3c)
and positive for the FACS markers CD9 and EpCAM (Fig. 3d).
Encouragingly, passage 25 ihPSFs maintained comparable
levels of pluripotent colonies of HUES1 and HUES3 to early
passage hPSFs and early passage MEFs (Table 3). Further-
more, HUES1 colonies grown on ihPSFs were able to form EBs
and differentiate into cell types representing all three germ
lineages as analysed by immunocytochemistry on replated
cells (Fig. 3e).
We conclude that a clonal human Placental Stromal
Fibroblasts cell line is able to support the derivation and
maintenance of hESc/hiPSc. Transgenic overexpression of
BMI-1 alone in hPSFs is sufficient to perpetuate a feeder cell
phenotype capable of maintaining hESc/hiPSc cultures over
at least 25 passages. The ectopic over expression of BMI-1
and hTERT is often used in cell biology to immortalise
primary cells as well as retain their phenotypic integrity.
However, our data imply that prolonged over-expression of
these two transgenes creates a propensity toward apoptosis,
possibly mediated through C-MYC, and ultimately degrada-
tion of the cell line. The clonal ihPSF cell line we have
generated was used to successfully derive a new hESc line in
near xenofree conditions in a clean room cGMP context.
ihPSFs are amenable to continued xenofree culture and
maintenance of both hESc and hiPSc making them an ideal
feeder layer for clinical grade pluripotent stem cell
derivation and scale-up.
Materials and methods
Isolation, purification, growth and maintenance of
primary cells
Human Placental Stromal Fibroblasts
First and early second trimester placentas were donated
after informed consent and under the guidelines set out
according to the National Research Ethics Service (07/
H1008/224). Chorionic villous tissue was dissected and
washed in DMEM medium (Lonza, Basel, Switzerland) con-
taining 2.5 μg/ml amphotericin B (Sigma-Aldrich, Poole, UK)
and penicillin/streptomycin (Invitrogen, Paisley, UK) (wash
medium),then cut into 5 mm2 sections and subjected to 3
low-g (300×g) centrifugations in 50 ml of wash medium to
159Human feeder cell line for derivation and culture of hESc/hiPScremove blood cells. It was treated with trypsin-EDTA
(Invitrogen)/DNase I (Invitrogen) (0.125%/2 mg/ml final
concentration) in 15 ml wash medium and incubated at
37 °C for 35 min with resuspension every 5 min. Released
trophoblast was separated from tissue aggregates by
filtration through a 100 μm MESH filter. Aggregates were
washed repeatedly with wash medium on the MESH filter.
The trypsin-EDTA-DNase I treatment was repeated to remove
any remaining trophoblast and then human serum-containing
medium added to neutralise the trypsin. Aggregates were
then washed 3 times in wash medium prior to adding
collagenase/hyaluronidase (Sigma-Aldrich) (1.5 mg/ml col-
lagenase/2 mg/ml hyaluronidase) and incubation at 37 °C
for 2 h with shaking. Tissue clumps were removed by a low-g
(300×g) spin and the resultant single cell suspension
decanted and then serially washed with wash medium
followed by centrifugation at 1000×g. The cell pellet was
resuspended in growthmedium (DMEM) containing penicillin/
streptomycin, L-glutamine and 10% human serum (Invitrogen)
and plated onto 0.1% porcine gelatin (Sigma-Aldrich)-coated
plates.
For xenofree growth hPSF and ihPSF cultures were trypsin-
ised using Trypzean (Sigma-Aldrich), washed in PBS, pelleted
at 600×g, resuspended in xenofree growth medium (DMEM
(Lonza), 10% human serum (Lonza), penicillin/streptomycin)
and plated on 0.1% human gelatin (Fibrogen, San Franscisco,
CA, USA) coated plates. Cells were cryopreserved for long-term
storage in xenofree Profreeze (Lonza) medium.
Mouse Embryonic Fibroblasts
Mouse Embryonic Fibroblasts (MEF) were isolated, puri-
fied and prepared as described by Michalska (2007). MEFs
were routinely amplified on 0.1% porcine gelatin-coated
plates in DMEM medium supplemented with 10% FCS,
penicillin/streptomycin, L-glutamine.
Mitotic inactivation of hPSFs, ihPSFs and MEFs
Fibroblast feeder cells were plated and cultured as described
in T-75 flasks until 80% confluent. Growth medium was
replaced with growth medium supplemented with 10 μg/ml
Mitomycin C (Sigma-Aldrich) and incubated for 3 h for MEFs
and 6 h for hPSFs and ihPSFs at 37 °C, 5% CO2. Cells were then
serially washed 3 times in PBS, Trypsinised, counted using a
hemocytometer, resuspended in Profreeze cryopreservation
medium at 105 cells per vial and stored in liquid nitrogen.
Growth and maintenance of hES and hiPS cells
The hESc line HES3was obtained from ES Cell International Pte
Ltd (Singapore), HUES1 and 7 were a kind gift from Prof. Doug
Melton (University of Harvard). The hESc lines MAN-1 and
MAN-2 were derived at the North West Embryonic Stem Cell
Centre (NWESCC), University of Manchester. Human iPSc lines
iPSA and iPSB were generated at NWESCC using protocols
detailed by Takahashi et al. Mitotically inactivated hPSFs and
ihPSFswere plated onto 0.1% gelatin coated plastic (porcine or
human) at a density of 2.5×104 cells/cm2,MEFswereplatedat
3.5×104 cells/cm2 washed 3 times in PBS prior to applying
hESc growth medium (KO-DMEM, 20% KO-serum replacement,
2 mM L-glutamine, 1× non-essential amino acids and 100 μMβ-mercapoethanol (all Invitrogen) and8 ng/ml FGF2 (Peprotec,
London, UK)). All hESc/hiPSc lines were passaged by trypsin or
mechanical cutting. Xenofree cultures of hESc were grown on
inactivated xenofree PSFs grown on 0.1% human gelatin
coated plastic in xenofree hESc growth medium (KO-DMEM
(Invitrogen), 20% human serum replacement (Sigma-Aldrich),
2 mM L-glutamine, 1× non-essential amino acids and 100 μM
β-mercapoethanol (all Invitrogen) and 8 ng/ml FGF2 (R&D
Systems, Abingdon, UK)). All xenofree components were also
cGMP compliant.
Embryoid body formation and replating
Embryoid bodies were generated using Aggrewell plates as per
manufacturer's instructions (StemCell Technologies, Grenoble,
France). EBs were plated onto standard tissue culture plates
and grown in DMEM supplemented with 20% FCS for 14 days
prior to analysis.
Derivation of a new hESc line
Early cleavage stage embryos were donated by couples
undergoing IVF treatment at St Mary's Hospital after informed
consent with approval of Central Manchester Research Ethics
Committee and under licence R0171 from the Human
Fertilisation and Embryology Authority. They were cultured
in G1/2 sequential media until blastocyst formation. At the
blastocyst stage, the zona pellucida of the embryos were
removed by treatment with acid Tyrode's solution (pH 2.5,
Sigma-Aldrich) before mechanical disruption of the trophec-
toderm (TE), with the aid of two pulled glass Pasteur pipettes,
one with a cutting open end and the other with a closed round
end. The part of the cell clump containing the inner cell mass
(ICM) was gently triturated and washed in a fresh drop of ES
medium, and transferred onto a layer of the mitotically
inactivated (10 μg/ml of mitomycin C for 6 h) immortalised
hPSFs in an organ culture dish. After 6–8 days culture or until
outgrowths appeared (Passage 0), the outgrowth of ICM was
split into several pieces by manual dissection and transferred
to new feeder layers each 5–8 days thereafter.
Viral construction, production, transduction and
selection of hPSFs
The MLV-based retroviral vector expressing hTERT (human
Telomerase catalytic domain) in a bicistronic cassette with
the puromycin resistance gene and control empty vector
were kindly supplied by Cancer Research UK. The lentiviral
vector expressing the human BMI-1 gene in a bicistronic
cassette with eGFP and control eGFP vector were con-
structed using 2nd generation HIV-1 based lentiviral cas-
settes as previously described (Godfrey et al., 2005). Human
BMI-1 full length cDNA was obtained from geneservice™ as a
Mammalian Gene Collection (MGC) Clone, IMAGE Id number
40125787 within the pOTB7 vector. The ~3.2 kb BMI-1 cDNA
was excised from this vector by restriction digest with BamHI
and XhoI and ligated into the multiple cloning site (MCS) of
the similarly cut lentiviral vector pHR-EF1α-MCS-IRES-GFP.
All clones were validated by complete sequencing.
Viral preparation was carried out by transient transfec-
tion of 293T producer cells with the viral plasmid as detailed
160 T.R. McKay et al.below and the VSV-G encoding plasmid pMD.G2 and the viral
helper plasmid; pCMVdelta8.74 for the lentivirus and pKat
for the retrovirus. Briefly, 293T transfections were carried
out using calcium phosphate precipitation. Virus containing
supernatant was harvested after 48 h and filtered through a
0.45 μm nylon membrane (Millipore, Watford, UK). Trans-
duction of hPSFs was carried out using application of
unconcentrated viral supernatant after pre-incubation with ii i
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Table 3 A comparison of hESc colonies grown on ihPSFs,
hPSFs and MEFs. hESc colonies were cultured on either
immortalised PSFs (ihPSF; p25), primary early passage PSFs
(hPSF; p4) or early passage MEFs (p4). Colonies were
maintained for at least 4 passages then analysed with the
pluripotency markers CD9 and EpCAM by FACS. Plots are
shown in Fig. 3d.
ihPSF hPSF MEF
HUES1 CD9 85.9 84.1 82.1
EpCAM 82.6 81.7 74.4
HUES3 CD9 67.3 69.2 83.1
EpCAM 69.2 66.7 74.1
161Human feeder cell line for derivation and culture of hESc/hiPScwere subjected to extended passage they were re-selected
with 5 days of puromycin treatment after every 25 days.
Expression analyses
Immunocytochemistry
Monoclonal antibodies for human pluripotency markers
(OCT4, Nanog and SSEA3), fibroblast specific protein, CD45,
CD31 and K18 and appropriate FITC and TRITC labelled
secondary antibodies were all purchased from R&D Systems.
Immunocytochemistry was carried as follows. Briefly, cells
were fixed with ice cold 4% paraformaldehyde for 20 min,
washed 3 times in PBS, blocked with 10% goat serum in wash
buffer (0.1% Triton in PBS) for 30 min. Primary antibody was
applied at the manufacturer recommended concentration in
wash buffer with 1% goat serum and incubated overnight at
4 °C. Cells were washed 3 times in wash buffer then
secondary antibody applied in wash buffer containing 1%
goat serum and incubated at room temperature for 2 h. Cells
were again washed 3 times in wash buffer then counter-
stained with DAPI containing mounting medium (Vector
Laboratories, Peterborough, UK) a coverslip applied and
visualised using an Olympus IX71 fluorescence microscope
(Olympus, Watford, UK).
Flow cytometry for cell surface markers
Human ESc lines were grown for at least 4 passages on
inactivated MEFs, hPSFs and ihPSFs. The cultures were
treated with collagenase to eliminate the feeder cell
population and the final single cell suspension was prepared
by incubating the detached stem cell colonies with TrypLe
(GIBCO) for 2 min at 37 °C. The cells were blocked with PBS+Figure 3 ihPSFs are able to support near xenofree derivation andm
new hESc line (MAN-3) was carried out on ihPSFs from a donated day
day 3 after plating; (iii) established colonies at P3. All standard
environment with xenofree reagents except for Knockout Serum Re
xenofree medium was assessed by cell counting over 14 days (n=4±s.
xenofree medium. (c) Pluripotency was confirmed by immunostainin
counterstained with DAPI and are representative of 3 separate staini
MAN-1. (d) HUES1 and HUES3 colonies were grown for at least 4 pas
assayed for the pluripotency markers CD9 and EpCAM. (e) The ability
embryoid bodies, replating and immunostaining for the neurectoderm
markers (iii) smooth muscle actin and (iv) vimentin, and the endoder
shown is for HUES7. Immunocytochemistry experiments were accom
negative for all markers (size bars throughout represent 10 μm).0.1% FBS which were then incubated at 4 °C overnight with
FITC-conjugated monoclonal mouse antibodies CD9 and
EpCAM (both from R&D Systems) or mouse IgG (1:100)
(Santa-Cruz). After the incubation the cells were washed 3
times with PBS+0,1% FBS. The immunological control
samples were incubated with AlexaFluor 488 (Invitrogen)
for 1 h at room temperature which was followed by further
washes with PBS+0.1% FBS. All the samples were diluted in
PBS for real-time analysis with Beckman Coulter Cyan ADP
(The University of Manchester) and the data analysed using
Summit V4.3.02 Build2451 Software.
Cell derived matrix preparation
Inactivated primary and immorto human placental fibro-
blasts were seeded at a density of 0.068×106 cells/cm2 on
0.1% gelatin-coated plates and cultured for 14 days before
extracting the matrices. Extracellular matrix was derived
from the cells using 20 mM NH4OH and 0.5% TritonX-100
extraction buffer. Matrix was then treated with 10 U/ml
DNAase I (Promega) for 30 min at 37 °C and washed two
times with PBS. Matrix was solubilised using 300 μl of pre-
warmed 2× sample buffer prepared by diluting 5× sample
buffer containing 10% SDS, 25% glycerol, 125 mM Tris–HCl pH
6.8, 0.01% Bromophenol Blue, 20% β-mercaptoethanol
(Sigma) in distilled water. The matrix was removed from
the plate using a cell scraper and the samples were stored at
−80 °C for further use.
Western blotting
Protein expression was analysed by western blotting using
standard methodology. Blots were blocked with 5% milk
powder, 0.05% Tween in PBS. The BMI-1 human monoclonal
antibody was purchased from Upstate Antibodies (Millipore),
the monoclonal human Ink4a/p16, p21 and β-actin anti-
bodies were purchased from AbCam (Cambridge, UK) and the
fibronectin antibody was purchased from Sigma-Aldrich.
Telomerase assay
Telomerase activity was assayed as per manufacturer's
instructions (TRAPeze® XL Telomerase Detection Kit, Che-
micon International, (Millipore)). Briefly, lysate from 1×103
cells was added to a reaction mix containing a substrate
oligonucleotide, onto which any active telomerase withinaintain hESc/hiPSc in a xenofree environment. (a) Derivation of a
6 blastocyst (i). (ii) Attached outgrowth on inactivated ihPSFs at
operating procedures were carried out in a cGMP compliant
placement. (b) Their ability to maintain ihPSF proliferation in
e.m.) prior to culturing HUES7 colonies for at least six passages in
g for OCT4, Nanog and SSEA3 (right panel phase image). Images
ng experiments using HUES7. Similar results were achieved with
sages on MEFS (red), hPSFs (green) and ihPSFs (p25) (blue) then
to differentiate to the 3 germ lineages was assayed by forming
markers; (i) β-tubulin III and (ii) neurofilament, the mesoderm
m markers (v) alpha fetoprotein and (vi) SOX17. Immunostaining
panied with the appropriate isotype antibody controls that were
162 T.R. McKay et al.the lysates would add GGTTAG telomeric repeats. Subse-
quent PCR amplification of the extended products with
Amplifluor® primers containing a 5′ fluorescein fluorophore
and 3′ DABSYL quencher generated a fluorescence emission
directly proportional to the amount of active telomerase in
the cells. Heat treated lysate was used as a negative control
and a standard curve was obtained using serial dilutions of
the supplied control template. An internal control template
utilising a sulforhodamine fluorophore removed artefactal
differences due to PCR inhibition.
TUNEL assay
Apoptosis was assessed using the terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick endlabeling (TUNEL).
Briefly, HUES-1 cells were fixed at appropriate time points in
4% paraformaldehyde and permeabilised with 0.1% Triton
X-100. As a positive control, cells were incubated in 50 μl of
DNase 3 U/ml in 50 mM Tris–HCL (Roche, Burgess Hill, UK) for
20 min before TUNEL staining. TUNEL labelling was carried
out using an In Situ Cell Death Detection Kit, FlTC conjugated
(Roche) according to the manufacturer's instructions. After
TUNEL labelling the cells were washed in PBS to remove any
unbound material and mounted in Vectashield containing
DAPI and photographed using an Olympus IX71 epifluores-
cence microscope (Olympus Optical Ltd., Tokyo, Japan).
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.scr.2011.04.005.
Acknowledgments
This work was funded by the North West Development
Agency (NWDA) and the group was supported by the NIHR
Manchester Biomedical Research Centre. Ethical approval
for this project is held through the National Research Ethics
Service administered through the Central Manchester Re-
search Ethics Committee Ref: 07/H1008/224. We also wish to
thank Geraint Wilde for assisting in image analysis using the
Chipman Technologies Cell-IQ platform.
References
Choo, A., Padmanabhan, J., Chin, A., Fong, W.J., Oh, S.K., 2006.
Immortalized feeders for the scale-upof humanembryonic stemcells
in feeder and feeder-free conditions. J. Biotechnol. 122, 130–141.
Choo, A., Ngo, A.S., Ding, V., Oh, S., Kiang, L.S., 2008. Autogeneic
feeders for the culture of undifferentiated human embryonic
stem cells in feeder and feeder-free conditions. Methods Cell
Biol. 86, 15–28.Deleu, S., et al., 2009. Human cystic fibrosis embryonic stem cell
lines derived on placental mesenchymal stromal cells. Reprod.
Biomed. Online 18, 704–716.
Escobedo-Lucea, C., Stojkovic, M., 2010. Growth of human
embryonic stem cells using derivates of human fibroblasts.
Methods Mol. Biol. 584, 55–69.
Fulcher, M.L., et al., 2009. Novel human bronchial epithelial cell
lines for cystic fibrosis research. Am. J. Physiol. Lung Cell. Mol.
Physiol. 296, L82–91.
Godfrey, A., Anderson, J., Papanastasiou, A., Takeuchi, Y., Boshoff,
C., 2005. Inhibiting primary effusion lymphoma by lentiviral
vectors encoding short hairpin RNA. Blood 105, 2510–2518.
Guney, I., Wu, S., Sedivy, J.M., 2006. Reduced c-Myc signaling
triggers telomere-independent senescence by regulating Bmi-1
and p16(INK4a). Proc. Natl. Acad. Sci. U.S.A. 103, 3645–3650.
Haga, K., et al., 2007. Efficient immortalization of primary human
cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined
with introduction of hTERT. Cancer Sci. 98, 147–154.
Hernandez, D., Ruban, L., Mason, C., 2011. Feeder-free culture of
human embryonic stem cells for scalable expansion in a
reproducible manner. Stem Cells Dev. 20, 1089–1098.
Ilic, D., Kapidzic, M., Genbacev, O., 2008. Isolation of human
placental fibroblasts. Curr. Protoc. Stem Cell Biol. 6 (Chapter 1,
Unit 1 C).
Larijani, M.R., et al., 2011. Long-term maintenance of undiffer-
entiated human embryonic and induced pluripotent stem cells in
suspension. Stem Cells Dev. doi:10.1089/scd.2010.0517.
Li, W., et al., 2011. Simple autogeneic feeder cell preparation for
pluripotent stem cells. Stem Cell Res. 6, 83–89.
Liu, T., et al., 2010. Human amniotic epithelial cell feeder layers
maintain mouse embryonic stem cell pluripotency via epigenetic
regulation of the c-Myc promoter. Acta Biochim. Biophys. Sin.
(Shanghai) 42, 109–115.
Michalska, A.E., 2007. Isolation and propagation of mouse embryonic
fibroblasts and preparation of mouse embryonic feeder layer
cells. Curr. Protoc. Stem Cell Biol. 3 (Chapter 1, Unit1C).
Milyavsky, M., et al., 2003. Prolonged culture of telomerase-
immortalized human fibroblasts leads to a premalignant pheno-
type. Cancer Res. 63, 7147–7157.
Rodin, S., et al., 2010. Long-term self-renewal of human pluripotent
stem cells on human recombinant laminin-511. Nat. Biotechnol.
28, 611–615.
Tecirlioglu, R.T., Nguyen, L., Koh, K., Trounson, A.O.,Michalska, A.E.,
2010. Derivation and maintenance of human embryonic stem cell
line on human adult skin fibroblast feeder cells in serum
replacement medium. In Vitro Cell. Dev. Biol. Anim. 46, 231–235.
Thomas, R.J., et al., 2009. Automated, scalable culture of human
embryonic stem cells in feeder-free conditions. Biotechnol.
Bioeng. 102, 1636–1644.
Unger, C., Skottman, H., Blomberg, P., Dilber, M.S., Hovatta, O.,
2008. Good manufacturing practice and clinical-grade human
embryonic stem cell lines. Hum. Mol. Genet. 17, R48–53.
Unger, C., et al., 2009. Immortalized human skin fibroblast feeder
cells support growth and maintenance of both human embryonic
and induced pluripotent stem cells. Hum. Reprod. 24,
2567–2581.
